Events /// Investor News /// Investment Case /// Resources
Bayer is committed to providing sustainable solutions that address humanity’s most fundamental needs for essential healthcare and nutritious food. The Bayer Investor Relations Team is dedicated to creating transparency, fostering dialogue, and delivering value to our stakeholders.
Upcoming Events and Highlights
Investor News
Share Price / Index
December 12, 2025
Not intended for U.S. and UK Media
Aflibercept 8 mg recommended for EU approval for third retinal indication
November 23, 2025
Bayer’s FXIa inhibitor Met Primary Efficacy and Safety Endpoints in Landmark Phase III Study in Secondary Stroke Prevention
Discover More
